SVSilvia Lo Vecchio

Silvia Lo Vecchio

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Silvia Lo Vecchio has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

  • Lars Arendt-Nielsen

    Center for Neuroplasticity and Pain (CNAP), Sensory-Motor Interaction (SMI) Center, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark

    16 shared publications
  • Parisa Gazerani

    Oslo Metropolitan University

    8 shared publications
  • Jesper Elberling

    Department of Dermatology and Allergy Herlev and Gentofte Hospital Denmark

    7 shared publications
  • Lars Arendt-Nielsen

    Centre for Neuroplasticity and Pain, SMI, Department of Health Science and Technology, School of Medicine , Aalborg University , Aalborg , Denmark

    6 shared publications
  • Thomas Graven-Nielsen

    Center for Neuroplasticity and Pain (CNAP), Department of Health Science and Technology, Faculty of Medicine Aalborg University Aalborg Denmark

    5 shared publications
  • Giulia Erica Aliotta

    Department of Health Science and Technology, Center for Neuroplasticity and Pain (CNAP) Aalborg University Aalborg Denmark

    4 shared publications

Latest Publications

  • Spatial and Temporal Summation of Histaminergic and Non‐Histaminergic Itch

    by Giulia Erica Aliotta, Silvia Lo Vecchio, Ryusuke Tanaka, Nicoline Stampe Batsberg, Sine Duch‐Svenson, Emilie Spagner Fernández, Mohammad Ali Hafiz, Nick Torp Holm, Kristian Herman Ladegaard, Meenuya Rajhmohan, et al.

    Chronic itch represents a social burden due to its high prevalence, negative impact on quality of life, and limited treatment options. Spatial (simultaneously applied stimuli at multiple skin sites) and temporal (repeated stimuli over time) summation are key mechanisms in itch processing but have not been investigated in detail in humans. This study assessed experimentally induced histaminergic and non‐histaminergic itch provocations in healthy volunteers. In the spatial summation experiment, histamine or cowhage was applied in randomized order to one area, two areas on the same arm, or two areas on different arms. Itch and pain intensities were recorded for 9 min, followed by assessment of alloknesis and hyperknesis. In the temporal summation experiment, each pruritogen was applied either once or repeatedly at intervals of 90 or 180 s apart to the forearm. Itch and pain intensities were recorded for 15 min, after which superficial blood perfusion (SBP), alloknesis, and hyperknesis were assessed. Itch intensity and calculated area under the curve (AUC) were significantly facilitated by special summation after both ipsilateral and contralateral applications of both pruritogens. Temporal summation significantly increased AUC after reapplication of either of the pruritogens after 180 s. Reapplication after 90 s significantly increased cowhage‐induced SBP, while reapplication after 180 s increased histamine‐induced SBP. In conclusion, spatial summation augmented itch intensity and AUC, whereas temporal summation increased AUC and enhanced SBP. Both effects were observed for histaminergic and non‐histaminergic itch, highlighting differences in fundamental mechanisms.

  • Open Access

    Experimental acute muscle pain and itch induce similar inhibitory effects on corticospinal excitability

    by Bolette Harritsø Winther, Lars Arendt-Nielsen, Johanne Bagger Graugaard, Hannah Grønlund Jespersen, Jesper Elberling, Enrico De Martino, Silvia Lo Vecchio

    Introduction: Pain and itch provoke different motor behaviors. Pain induces motor inhibition, whereas itch triggers an active scratching response. Acute pain is known to decrease corticospinal excitability, assessed by transcranial magnetic stimulation (TMS) through motor-evoked potentials (MEPs), but the effects of acute itch on bilateral corticospinal excitability are unknown. Objectives: We hypothesized that acute pain and itch differentially affect corticospinal excitability, decreasing and increasing MEPs, respectively. Methods: Nineteen healthy participants completed a 2-session, crossover study. Transcranial magnetic stimulation was applied targeting the right and left first dorsal interosseous (FDI) muscles. Motor-evoked potentials were recorded before, during experimentally induced pain (intramuscular hypertonic saline injection in the right FDI) or induced itch (cutaneous histamine application above the FDI), immediately after, and 30 minutes after provocation. Transcranial magnetic stimulation pulses were delivered every ∼7 seconds, and participants rated the pain and itch intensities using a numeric rating scale every ∼30 seconds. Results: Pain numeric rating scale scores were higher than itch scores from 0 to 120 seconds but lower at 390 seconds (all P < 0.05). Compared with baseline, both modalities reduced affected-hand MEPs (P = 0.003) with no changes in nonaffected-hand MEPs. Correlations between affected- and nonaffected-hand MEP reductions were found during pain (P = 0.009) and itch (P = 0.025). Conclusion: Opposite to the hypothesis, acute, experimental pain and itch induced similar corticospinal inhibition, suggesting a comparable effect on the motor output of the affected limb. This study found that the effects of acute pain and itch showed similar inhibition on bilateral corticospinal tract excitability.

  • Open Access

    Effect of Intradermal Morphine on Histaminergic and Non‐Histaminergic Itch: A Randomised, Single‐Blinded, Human Study

    by Silvia Lo Vecchio, Giulia Erica Aliotta, Hiroai Okutani, Nadia Ammitzbøll, Anne‐Marie Wegeberg, Asbjørn Mohr Drewes, Lars Arendt‐Nielsen

    Itch can be a side‐effect of drugs like opioids, with prevalence depending on the route of administration. This study aimed to investigate if morphine (1) induced itch and neurogenic inflammation after intradermal injection and (2) modulates the responses to locally experimentally induced histaminergic and non‐histaminergic itch. Twenty‐four healthy volunteers participated in this randomised, single‐blinded study. Two areas on the volar forearms of each participant were randomly treated with either intradermal morphine 0.05 mL (0.1 mg/mL) or saline (isotonic saline 0.05 mL), followed by assessment of itch intensity, wheal, and flare reactions. After injection, histamine and cowhage (non‐histaminergic itch) were randomly applied intradermally and topically, respectively at the sites of morphine/saline injection, and the assessments were repeated. Before saline/morphine injections (baseline measurement), after injections (post‐intervention measurement), and after pruritogen application (post‐pruritogen measurement), superficial blood perfusions were measured using full‐field laser perfusion imaging. Morphine induced increased peak itch intensity and itch area under the curve compared to saline, without further increase by the experimentally induced histaminergic and non‐histaminergic itch. Morphine also caused a larger wheal area compared to saline. Morphine increased superficial blood perfusion compared to saline both after treatment and after pruritogens. This study confirmed that (1) intradermal morphine induces spontaneous itch, (2) morphine induced neurogenic inflammation which alone and in combination with the pruritogens caused larger responses (wheal and flare) when compared with saline and (3) the itch intensities provoked by experimentally induced histaminergic and non‐histaminergic substances were not modulated when applied to the morphine‐treated areas.

  • Open Access

    The Role of Peripheral N‐Methyl‐D‐Asparate (NMDA) Receptors in Itch and Pain: A Narrative Review

    by Ryusuke Tanaka, Silvia Lo Vecchio, Giulia Erica Aliotta, Lars Arendt‐Nielsen

    Background and Objective: NMDA receptors, predominantly located in the central nervous system and known for their roles in synaptic plasticity and central sensitisation of pain and itch, are also expressed in peripheral sensory neurons. Emerging evidence suggests that peripheral NMDA receptors contribute to pathological pain and potentially itch, identifying them as promising therapeutic targets. The aim of this review is to explore the role of peripheral NMDA receptors in pain and itch and to summarise the effectiveness of topical NMDA antagonists in managing these sensations.Databases and Data Treatment: This review was conducted through a systematic search of the PubMed database using MeSH terms and keywords related to ‘peripheral NMDA receptors’, ‘pain’, ‘itch’ and ‘topical ketamine’. Additional references were included based on expert knowledge and reference tracking. Only English‐language articles were considered.Results: Animal studies demonstrate that peripheral NMDA receptors are involved in inflammatory and certain neuropathic pain models, with antagonists showing analgesic effects. Limited studies also suggest their role in non‐histaminergic itch through glutamate signalling. In humans, topical ketamine has shown mixed results for pain relief, and preliminary clinical reports suggest potential antipruritic effects. However, controlled clinical trials, particularly for itch, are lacking.Conclusion: Peripheral NMDA receptors are involved in the transmission and sensitisation of both pain and itch, especially under pathological conditions. While topical ketamine may offer therapeutic benefits, particularly for non‐histaminergic itch and neuropathic pain, further clinical research is necessary to confirm its efficacy, safety and optimal use.Significance Statement: This review highlights the underexplored role of peripheral NMDA receptors in itch, especially non‐histaminergic pathways, and synthesises emerging evidence for their therapeutic potential. By comparing pain and itch mechanisms, it suggests that topical ketamine could serve as novel treatments for refractory itch and localised pain, warranting further clinical investigation.


  • Effects of oral morphine on experimentally evoked itch and pain: a randomized, double-blind, placebo-controlled trial

    by Hiroai Okutani, Silvia Lo Vecchio, Nadia Ammitzbøll, Asbjørn Mohr Drewes, Lars Arendt-Nielsen

    Objectives: Pain and itch share similar neuronal networks; hence, it is difficult to explain why opioids can relieve pain but provoke itching. The present human volunteer study aimed to investigate the similarities and differences in responses to experimentally provoked pain and itching to explore the underlying fundamental mechanisms. Methods: Twenty-four healthy volunteers were enrolled in this single-center, randomized, double-blind, placebo-controlled, parallel-group trial. Three volar forearms and two mandibular areas were marked, and participants randomly received morphine (20 mg) or identical placebo tablets. Heat, cold, and pressure pain thresholds, and vasomotor responses were assessed at baseline and after oral morphine administration. Itch provocations were induced by intradermal application of 1 % histamine or a topical cowhage (non-histaminergic itch) to a marked area of the skin. The participants were subsequently asked to rate their itching and pain intensities. The assessments were repeated for all marked areas. Results: Morphine caused analgesia, as assessed by the significant modulation of cold and pressure pain thresholds (p<0.05). There were no significant differences in histaminergic or non-histaminergic itch or pain intensity between the morphine and placebo groups. Superficial blood perfusion (vasomotor response) following histamine provocation was significantly increased by morphine (p<0.05) in both areas. No correlation was found between the provoked itch intensity and analgesic efficacy in any area or group. Conclusions: Oral administration of morphine caused analgesia without modulating itch intensities but increased neurogenic inflammation in response to histamine, suggesting that different opioid mechanisms in histaminergic and non-histaminergic neurons evoke neurogenic inflammation.


  • Open Access

    Mechanisms and treatment of opioid‐induced pruritus: Peripheral and central pathways

    by Hiroai Okutani, Silvia Lo Vecchio, Lars Arendt‐Nielsen

    Background and Objective: Pruritus (also known as itch) is defined as an unpleasant and irritating sensation of the skin that provokes an urge to scratch or rub. It is well known that opioid administration can cause pruritus, which is paradoxical as itch and pain share overlapping sensory pathways. Because opioids inhibit pain but can cause itching. Significant progress has been made to improve our understanding of the fundamental neurobiology of itch; however, much remains unknown about the mechanisms of opioid‐induced pruritus. The prevention and treatment of opioid‐induced pruritus remains a challenge in the field of pain management. The objective of this narrative review is to present and discuss the current body of literature and summarize the current understanding of the mechanisms underlying opioid‐induced pruritus, and its relationship to analgesia, and possible treatment options.Results: The incidence of opioid‐induced pruritus differs with different opioids and routes of administration, and the various mechanisms can be broadly divided into peripheral and central. Especially central mechanisms are intricate, even at the level of the spinal dorsal horn. There is evidence that opioid receptor antagonists and mixed agonist and antagonists, especially μ‐opioid antagonists and κ‐opioid agonists, are effective in relieving opioid‐induced pruritus. Various treatments have been used for opioid‐induced pruritus; however, most of them are controversial and have conflicting results.Conclusion: The use of a multimodal analgesic treatment regimen combined with a mixed antagonist and κ agonists, especially μ‐opioid antagonists, and κ‐opioid agonists, seems to be the current best treatment modality for the management of opioid‐induced pruritus and pain.Significance: Opioids remain the gold standard for the treatment of moderate to severe acute pain as well as cancer pain. It is well known that opioid‐induced pruritus often does not respond to regular antipruritic treatment, thereby posing a challenge to clinicians in the field of pain management. We believe that our review makes a significant contribution to the literature, as studies on the mechanisms of opioid‐induced pruritus and effective management strategies are crucial for the management of these patients.


  • Open Access

    The effect of repetitive topical applications of local anesthetics (EMLA) on experimental pain and itch (histaminergic and nonhistaminergic)

    by Giulia Erica Aliotta, Silvia Lo Vecchio, Jesper Elberling, Lars Arendt-Nielsen

    Background: The effects of repeated topical applications of local anesthetics are poorly investigated as they may, in addition to analgesia, impact peripheral nerve endings in a cumulative manner. In the present study, the effects of 6 repetitive applications of eutectic mixture of lidocaine (EMLA 2.5% and prilocaine 2.5%) were investigated on experimentally induced pain, histaminergic and nonhistaminergic itch, and neurogenic inflammation. Methods: Four skin areas on the forearms of 24 subjects were randomized to receive 3 hours of application of EMLA or placebo twice a day for 3 consecutive days. After each application, superficial blood perfusion (SBP), mechanical (mechanically evoked itch, mechanical pain threshold, and mechanical pain sensitivity), and thermal sensitivity (warm detection threshold, heat pain threshold, and suprathreshold heat sensitivity) were assessed. After the last application of EMLA/placebo, histamine and cowhage was applied (2 areas each) and itch and pain intensity and SBP were assessed. Results: After 3 hours of EMLA application, significant mechanical and thermal hypoalgesia were found with no cumulative efficacy over the 3 days. EMLA alone had no effect on SBP. Significantly increased SBP, reduced cowhage-induced itch, but the unaffected histamine-induced itch was found when applying EMLA ahead of histamine and cowhage. Conclusions: EMLA induced a reduction of mechanical and thermal sensitivity without a cumulative-dose effect. EMLA reduced nonhistaminergic itch and pain but not the experimentally provoked histaminergic itch. Selective action of EMLA on polymodal C-fibers could explain these effects.


  • Open Access

    Antipruritic Effects of Doxepin Cream on Experimentally Induced Histaminergic and Nonhistaminergic Itch

    by Giulia Erica Aliotta, Silvia Lo Vecchio, Jesper Elberling, Lars Arendt-Nielsen

    Background. Itch can be transmitted by two parallel pathways, histaminergic and nonhistaminergic. Histaminergic itch is transmitted by a subgroup of mechano‐insensitive C‐fibers, while nonhistaminergic itch by a subgroup of polymodal C‐fibers. Experimental models are used to study pruritus: histamine for the histaminergic itch by antagonizing the histamine H1‐receptors, and BAM8‐22 and cowhage for the nonhistaminergic by activating Mas‐related G protein‐coupled receptors and protease‐activated receptors, respectively. This study aims to evaluate the antipruritic effects of topical doxepin (H1‐receptor antagonistic effect) on histaminergic and nonhistaminergic itch induced by histamine, BAM8‐22, and cowhage. Methods. This study was conducted on 22 healthy subjects. Histamine, BAM8‐22, cowhage, and vehicle were applied to 4 areas on the forearms. After 7 days, the same substances were applied after 11/2 hour‐pretreatment with doxepin. After the application of pruritogens, itch and pain intensities were assessed for 9 minutes, followed by the measurement of superficial blood perfusion (SBP), mechanical and thermal sensitivities. Results. Application of histamine, BAM8‐22, and cowhage all induced itch as compared to a vehicle. The pretreatment with doxepin almost abolished the histamine‐induced itch and modestly reduced BAM8‐22‐ and cowhage‐induced itch. Histamine induced a higher SBP compared to the other conditions. Doxepin reduced SBP induced by each pruritogen, even though SBP of histamine remains the highest. Conclusion. Doxepin cream abolished histaminergic itch by antagonizing the peripheral H1‐histamine receptors. Moreover, doxepin reduced nonhistaminergic itch and related neurogenic inflammation. Further studies are needed to elucidate the molecular mechanisms underlying this peripheral modulation of nonhistaminergic itch by a topically applied H1‐antagonist. This trial is registered with NCT04588532.


  • Open Access

    The temporal expression of circulating microRNAs after acute experimental pain in humans

    by Rocco Giordano, Maria Carla Gerra, Hiroai Okutani, Silvia Lo Vecchio, Allan Stensballe, Kristian Kjær‐Staal Petersen, Lars Arendt‐Nielsen

    Background: MicroRNAs (miRNAs) can modulate several biological systems, including the pain system. This study aimed to evaluate the temporal expression of circulating miRNAs in the plasma of healthy volunteers as a marker for epigenetic changes before and after an acute, experimental, pain provocation by intramuscular hypertonic saline injection.Methods: Twenty volunteers were randomly allocated into two groups and received either hypertonic (pain) or isotonic (control) saline injection in the first dorsal interosseous muscle of their dominant hand. Pain intensity was continuously recorded for 20 minutes after injection on a VAS scale from 0 to 100 (0 indicates no pain and 100 the worst imaginable pain). Blood samples were taken at baseline, 30 minutes, 3 hours, and 24 hours post‐injection, and plasma was separated. MiRNA extracts were used for RNA sequencing with the Illumina NextSeq platform. MiRNA transcripts were compared between the pain and the no‐pain, control group at every time point. Significant differences were considered when folds were >2 and the False Discovery Rate wasp < 0.05.Results: After 30 minutes, 4 miRNAs were significantly altered in the pain group compared to controls, which increased to 24 after 3 hours and to 42 after 24 hours from baseline (p < 0.0001). Two miRNAs were consistently upregulated throughout the experiment. Enrichment analysis showed significant miRNAs involved in brain perception of pain, brain signalling and response to stimuli.Conclusions: This exploratory study is the first to report on the temporal expression of circulating miRNAs after an acute, human experimental muscle pain model.Significance: This exploratory study evaluated the temporal profile of circulating miRNAs in the plasma of healthy subjects after acute experimental pain. Several miRNAs were altered in subjects at the times of follow‐up after the acute pain model when compared to controls. MiRNAs previously associated with pain processes were altered in the pain group. Our results, by showing the fast and prolonged modifications of miRNA elicited by the acute experimental pain model, add new perspectives to the topic of epigenetics and pain.


  • Open Access

    Papain as a Potential New Experimental Model of Non-histaminergic Itch

    by Giulia Erica Aliotta, Zeinab Saii, Jesper Elberling, Lars Arendt-Nielsen, Silvia Lo Vecchio

    Is missing (Short communication)